Celltrion (Korea) Performance
| 068270 Stock | 194,400 500.00 0.26% |
The firm shows a Beta (market volatility) of -0.41, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Celltrion are expected to decrease at a much lower rate. During the bear market, Celltrion is likely to outperform the market. At this point, Celltrion has a negative expected return of -0.0414%. Please make sure to confirm Celltrion's jensen alpha, treynor ratio, and the relationship between the standard deviation and total risk alpha , to decide if Celltrion performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Celltrion has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Celltrion is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Celltrion |
Celltrion Relative Risk vs. Return Landscape
If you would invest 20,200,000 in Celltrion on September 26, 2024 and sell it today you would lose (760,000) from holding Celltrion or give up 3.76% of portfolio value over 90 days. Celltrion is generating negative expected returns and assumes 2.0878% volatility on return distribution over the 90 days horizon. Simply put, 18% of stocks are less volatile than Celltrion, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Celltrion Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Celltrion's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Celltrion, and traders can use it to determine the average amount a Celltrion's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0198
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 068270 |
Estimated Market Risk
| 2.09 actual daily | 18 82% of assets are more volatile |
Expected Return
| -0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Celltrion is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Celltrion by adding Celltrion to a well-diversified portfolio.
Celltrion Fundamentals Growth
Celltrion Stock prices reflect investors' perceptions of the future prospects and financial health of Celltrion, and Celltrion fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Celltrion Stock performance.
| Price To Earning | 57.70 X | |||
| Cash And Equivalents | 125.54 B | |||
| Total Debt | 631.22 B | |||
| Debt To Equity | 0.32 % | |||
| Cash Flow From Operations | 113.85 B | |||
| Total Asset | 28.46 B | |||
| Retained Earnings | (22 M) | |||
| Current Asset | 10.78 B | |||
| Current Liabilities | 12.75 B | |||
About Celltrion Performance
By analyzing Celltrion's fundamental ratios, stakeholders can gain valuable insights into Celltrion's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Celltrion has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Celltrion has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Celltrion, Inc. researches, develops, manufactures, and sells biopharmaceutical solutions in South Korea and internationally.Things to note about Celltrion performance evaluation
Checking the ongoing alerts about Celltrion for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Celltrion help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Celltrion generated a negative expected return over the last 90 days |
- Analyzing Celltrion's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Celltrion's stock is overvalued or undervalued compared to its peers.
- Examining Celltrion's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Celltrion's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Celltrion's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Celltrion's stock. These opinions can provide insight into Celltrion's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Celltrion Stock analysis
When running Celltrion's price analysis, check to measure Celltrion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celltrion is operating at the current time. Most of Celltrion's value examination focuses on studying past and present price action to predict the probability of Celltrion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celltrion's price. Additionally, you may evaluate how the addition of Celltrion to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stocks Directory Find actively traded stocks across global markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Global Correlations Find global opportunities by holding instruments from different markets |